Herbert Virgin Vir Biotechnology, Inc. (VIR) insider trading activity

Herbert Virgin is EVP, Research & CSO of Vir Biotechnology, Inc.. Currently has a direct ownership of 262,500 shares of VIR, which is worth approximately $1.76 Million. The most recent transaction as insider was on Jun 01, 2021, when has been sold 1,375 shares (Common Stock) at a price of $42.51 per share, resulting in proceeds of $58,451. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

0% 3M change

0% 12M change

Total Value Held $1.76 Million

Herbert Virgin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 01 2021	SELL Open market or private sale	$58,451 $42.51 p/Share	1,375 Reduced 1.48%	91,700 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.46%	93,075 Common Stock
May 18 2021	SELL Open market or private sale	$61,916 $45.03 p/Share	1,375 Reduced 1.48%	91,700 Common Stock
May 18 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.46%	93,075 Common Stock
May 04 2021	SELL Open market or private sale	$63,291 $46.03 p/Share	1,375 Reduced 1.48%	91,700 Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.46%	93,075 Common Stock
Apr 27 2021	SELL Open market or private sale	$391,050 $49.5 p/Share	7,900 Reduced 7.93%	91,700 Common Stock
Apr 27 2021	BUY Exercise of conversion of derivative security	$12,087 $1.53 p/Share	7,900 Added 7.35%	99,600 Common Stock
Apr 19 2021	SELL Open market or private sale	$112,320 $48.0 p/Share	2,340 Reduced 2.49%	91,700 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$3,580 $1.53 p/Share	2,340 Added 2.43%	94,040 Common Stock
Apr 16 2021	BUY Exercise of conversion of derivative security	$5,355 $1.53 p/Share	3,500 Added 3.68%	91,700 Common Stock
Apr 13 2021	SELL Open market or private sale	$242,249 $43.57 p/Share	5,560 Reduced 5.93%	88,200 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	$8,507 $1.53 p/Share	5,560 Added 5.6%	93,760 Common Stock
Apr 09 2021	BUY Exercise of conversion of derivative security	$21,420 $1.53 p/Share	14,000 Added 13.7%	88,200 Common Stock
Mar 23 2021	SELL Open market or private sale	$423,440 $53.6 p/Share	7,900 Reduced 9.62%	74,200 Common Stock
Mar 23 2021	BUY Exercise of conversion of derivative security	$12,087 $1.53 p/Share	7,900 Added 8.78%	82,100 Common Stock
Mar 10 2021	SELL Open market or private sale	$112,320 $48.0 p/Share	2,340 Reduced 3.06%	74,200 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$3,580 $1.53 p/Share	2,340 Added 2.97%	76,540 Common Stock
Mar 09 2021	SELL Open market or private sale	$249,088 $44.8 p/Share	5,560 Reduced 6.97%	74,200 Common Stock
Mar 09 2021	BUY Exercise of conversion of derivative security	$8,507 $1.53 p/Share	5,560 Added 6.52%	79,760 Common Stock
Feb 23 2021	SELL Open market or private sale	$503,546 $63.74 p/Share	7,900 Reduced 9.62%	74,200 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	$28,917 $1.53 p/Share	18,900 Added 18.71%	82,100 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	30,000 Added 32.19%	63,200 Common Stock
Feb 09 2021	SELL Open market or private sale	$562,164 $71.16 p/Share	7,900 Reduced 19.22%	33,200 Common Stock
Feb 09 2021	BUY Exercise of conversion of derivative security	$12,087 $1.53 p/Share	7,900 Added 16.12%	41,100 Common Stock

Herbert Virgin

EVP, Research & CSO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Value

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR

Account